Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,699.45
(
0.02%
)
News Focus
News Focus
Post# of 257484
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122926
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 219997

Friday, 11/09/2018 5:24:21 PM

Friday, November 09, 2018 5:24:21 PM

Post# of 257484
FDA approves Keytruda monotherapy for second-line HCC:

https://finance.yahoo.com/news/fda-approves-merck-keytruda-pembrolizumab-212100345.html

This is an accelerated approval based on ORR (17%) and duration of response in the single-arm KEYNOTE-224 study. Patients were either refractory to, or ineligible for, Sutent, or had Child-Pugh-A cirrhosis. Today is the PDUFA date.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today